Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tasigna (nilotinib) / Novartis, Inhibikase

NCT00976612: Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Completed

N/A

RoW

Nilotinib

Asan Medical Center

Gastrointestinal Stromal Tumors

08/11

12/11

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites